Quantcast
Home > Quotes > ANIP
x

ANI Pharmaceuticals, Inc. (ANIP) Quote & Summary Data

ANIP 
$54.57
*  
0.19
0.35%
Get ANIP Alerts
*Delayed - data as of Oct. 15, 2018  -  Find a broker to begin trading ANIP now
Exchange:NASDAQ
Industry: Health Care
Community Rating:
 
 
Symbol List Views
FlashQuotes InfoQuotes
Stock Details
Summary Quote Real-Time Quote After Hours Quote Pre-market Quote Historical Quote Option Chain
CHARTS
Basic Chart Interactive Chart
COMPANY NEWS
Company Headlines Press Releases Market Stream
STOCK ANALYSIS
Analyst Research Guru Analysis Stock Report Competitors Stock Consultant Stock Comparison
FUNDAMENTALS
Call Transcripts Annual Report Income Statement Revenue/EPS SEC Filings Short Interest Dividend History
HOLDINGS
Ownership Summary Institutional Holdings Insiders
(SEC Form 4)
 Save Stocks

Key Stock Data

Best Bid / Ask
N/A / $ 66.11
Today's High / Low
$ 55 / $ 53.6074
Share Volume
61,065
50 Day Avg. Daily Volume
97,760
Previous Close
$ 54.38
52 Week High / Low
$ 74.70 / $ 49.76
Market Cap
645,495,488
Annualized Dividend
N/A
Ex Dividend Date
N/A
Dividend Payment Date
N/A
Current Yield
0 %

Intraday Chart

Shares Traded

Share Volume:
61,065
50 Day Avg. Daily Volume:
97,760

P/E Ratio

P/E Ratio:
NE
Forward P/E (1y):
12.11
Earnings Per Share (EPS):
$ -0.01

Trading Range

The current last sale of $54.57 is 9.67% Higher than the 52 week low.

Intraday Last 52 Weeks
High: $ 55 $ 74.70
 Low: $ 53.6074 $ 49.76

Company Description (as filed with the SEC)

ANI Pharmaceuticals is an integrated specialty pharmaceutical company focused on delivering value to our customers by developing, manufacturing, and marketing high quality branded and generic prescription pharmaceuticals. We focus on niche and high barrier to entry opportunities including controlled substances, anti-cancer (oncolytics), hormones and steroids, and complex formulations. Our two pharmaceutical manufacturing facilities located in Baudette, Minnesota are capable of producing oral solid dose products, as well as liquids and topicals, controlled substances, and potent products that must be manufactured in a fully-contained environment. Our objective is to create long term shareholder value by building a sustainable and growing base business in generic and mature brand pharmaceutical products while advancing an opportunity to re-commercialize Cortrophin gel and Cortrophin-Zinc.  ... More ...  


Risk Grade

Where does ANIP fit in the risk graph?


Risk Grade Scale

Nasdaq Official Price

Open Price:
$ 54.31
Open Date:
Oct. 15, 2018
Close Price:
$ 54.57
Close Date:
Oct. 15, 2018

Consensus Recommendation

Analyst Info